Hepatocellular Carcinoma in a non-Cirrhotic Liver of a HCV-Positive Woman with Sustained Viral Response.
作者信息
Nosotti L, D'Arca T, Marignani M, Balducci G
机构信息
National Institute of Health, Migration and Poverty, Rome, Italy.
出版信息
Mediterr J Hematol Infect Dis. 2011;3(1):e2011050. doi: 10.4084/MJHID.2011.050. Epub 2011 Oct 26.
Abstract
摘要
相似文献
1
Hepatocellular Carcinoma in a non-Cirrhotic Liver of a HCV-Positive Woman with Sustained Viral Response.
Mediterr J Hematol Infect Dis. 2011;3(1):e2011050. doi: 10.4084/MJHID.2011.050. Epub 2011 Oct 26.
2
Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
Gastroenterology. 2014 Jan;146(1):222-32.e35. doi: 10.1053/j.gastro.2013.09.025. Epub 2013 Sep 19.
3
Anti-HCV antibody in Chinese cirrhotic patients with or without hepatocellular carcinoma: relation to multitransfusion.
J Gastroenterol Hepatol. 1992 Mar-Apr;7(2):128-31. doi: 10.1111/j.1440-1746.1992.tb00948.x.
4
Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman.
Int J Infect Dis. 2014 Dec;29:100-2. doi: 10.1016/j.ijid.2014.08.011. Epub 2014 Oct 24.
5
Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma.
J Hepatol. 1998 Dec;29(6):887-92. doi: 10.1016/s0168-8278(98)80115-3.
6
Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis.
Braz J Infect Dis. 2010 Sep-Oct;14(5):457-61.
7
Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue.
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1375-80. doi: 10.1073/pnas.1516879113. Epub 2016 Jan 19.
8
Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Liver Int. 2016 Mar;36(3):434-44. doi: 10.1111/liv.12927. Epub 2015 Sep 29.
9
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma.
Liver Int. 2019 Oct;39(10):1986-1998. doi: 10.1111/liv.14168. Epub 2019 Jul 16.
10
The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen.
J Hepatol. 2018 Apr;68(4):646-654. doi: 10.1016/j.jhep.2017.10.033. Epub 2017 Nov 16.
引用本文的文献
1
A rare presentation of hepatocellular carcinoma in non-cirrhotic liver.
Pan Afr Med J. 2017 Sep 22;28:69. doi: 10.11604/pamj.2017.28.69.13512. eCollection 2017.
2
[Non fibrolamellar hepatocellular carcinoma on a healthy liver].
Pan Afr Med J. 2014 Jun 18;18:155. doi: 10.11604/pamj.2014.18.155.2762. eCollection 2014.
本文引用的文献
1
Medical treatment of hepatocellular carcinoma.
Mediterr J Hematol Infect Dis. 2009 Dec 16;1(3):e2009021. doi: 10.4084/MJHID.2009.021.
2
Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy.
Int J Cancer. 2011 May 15;128(10):2344-52. doi: 10.1002/ijc.25585.
3
Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers.
Mod Pathol. 2010 Feb;23(2):276-83. doi: 10.1038/modpathol.2009.174. Epub 2009 Nov 20.
4
Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal.
Dig Liver Dis. 2010 May;42(5):341-7. doi: 10.1016/j.dld.2009.09.002. Epub 2009 Oct 13.
5
Review on sample preparation strategies and methods used for the analysis of aflatoxins in food and feed.
Mol Nutr Food Res. 2009 Apr;53(4):508-24. doi: 10.1002/mnfr.200800145.
6
Hepatocellular carcinoma in a hepatitis C patient with sustained viral response and no fibrosis.
Ann Hepatol. 2009 Jan-Mar;8(1):64-7.
7
Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.
Hepatology. 2009 Mar;49(3):851-9. doi: 10.1002/hep.22734.
8
Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.
J Viral Hepat. 2008 Sep;15(9):659-65. doi: 10.1111/j.1365-2893.2008.01006.x. Epub 2008 Jul 10.
9
Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.
Ann Intern Med. 2007 May 1;146(9):649-56. doi: 10.7326/0003-4819-146-9-200705010-00008.
10
Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients.
Liver Int. 2007 Mar;27(2):186-91. doi: 10.1111/j.1478-3231.2006.01406.x.
Zotero 插件